INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a ...

EVA Pharma manufactures the injection in partnership ... established a new biologics manufacturing facility, completed stability testing and finalised insulin formulations, along with gaining ...

Key Features of Cadila Pharmaceuticals’ Aqueous Cholecalciferol Injection: Superior Pharmacokinetics and Pharmacodynamics: The novel aqueous formulation demonstrates significant improvements in ...